GLP-1 Is Reshaping the Grocery Basket. Is Your Portfolio Ready?
By now, most of us know the shift: GLP-1 users are cutting back on snacks, fast food, and sugary drinks, leaning instead into protein, fibre, and vegetables. Supermarket buying teams have had time to react, and nutrient-dense products in smaller formats are already appearing on shelves. But the data suggests there's a lot more to plan for.
The numbers behind the shift
Recent YouGov data shows UK consumers on weight-loss drugs have reduced their weekly grocery spend by 11%. The behavioural changes driving that number are striking: GLP-1 users are cutting snacks by 64%, fast food by 53%, and alcohol by 39%, while increasing vegetables (+38%), vitamins (+23%), and fish (+21%).
This isn't confined to the UK. Germany, France, and the Nordics combine high obesity prevalence with a strong culture of proactive health management, creating ideal conditions for targeted new product development. Brands and retailers that move early in these markets stand to capture a consumer base actively looking for products to support their health goals and currently underserved.
It's not just what they eat. It's how food tastes to them.
New research from MMR Research adds another layer: almost two-thirds of current GLP-1 users report their cravings have declined since starting treatment. As MMR's Andrew Wardlaw put it, this may mark the beginning of the end of craving as a purchase driver.
That shift shows up in taste perception too. Among GLP-1 users who noticed a change, nearly half found sweetness more intense than before, and one in five began avoiding certain textures altogether. The bold flavours, rich textures, and high sweetness levels long used to signal indulgence may no longer land the same way. When instant satisfaction stops driving purchase decisions, big, punchy flavour profiles lose their strongest hook, and buying teams lose a reliable shortcut for what sells.
Where the opportunity lies
GLP-1 users aren't just eating less. They need to eat smarter, protecting muscle mass while eating fewer calories means every bite has to work harder. That points to clear NPD opportunities:
High-protein snacks, bars, and drinks to preserve muscle during weight loss
Small-format, nutrient-dense ready meals with higher fibre and lower calories
Functional beverages supporting metabolic health and satiety
Supplement formats addressing nutritional gaps from reduced food intake
Portion-smart indulgence: reformulated baked goods, ice creams, and dairy with lower sugar and higher protein
For private label specifically, the window is real. Kantar data shows 44% of UK GLP-1 users have already switched grocery retailer, actively seeking products that support their journey. Private label can lead here without the premium price tag of branded alternatives.
The catch: don't build one range for everyone
Reformulating an entire portfolio around GLP-1 users risks alienating everyone else. The opportunity isn't a single universal "healthier" range. It's targeted, portfolio-level innovation: distinct products for distinct shopper needs, developed and sourced fast enough to keep pace with how quickly this segment is growing.
That speed is the real constraint. Most buying teams don't have a 12-month development cycle to spare while a fast-moving consumer segment reshapes category expectations in real time.
Where Kwayga fits in
Kwayga helps buying teams find the right suppliers for private label and trending food, drink, and near-food products, fast enough to act on shifts like this one instead of watching them play out on a competitor's shelf first.
How is your portfolio strategy adapting to this? Book a demo of Kwayga today.
